Results
|
1.
|
|
|
2.
|
|
|
3.
|
Larotaxel with Cisplatin in the first-line treatment of locally advanced/metastatic urothelial tract or bladder cancer: a randomized, active-controlled, phase III trial (CILAB). [electronic resource] by
- Sternberg, Cora N
- Skoneczna, Iwona A
- Castellano, Daniel
- Theodore, Christine
- Blais, Normand
- Voog, Eric
- Bellmunt, Joaquim
- Peters, Frank
- Le-Guennec, Solenn
- Cerbone, Linda
- Risse, Marie-Laure
- Machiels, Jean-Pascal
Producer: 20140116
In:
Oncology vol. 85
Availability: No items available.
|
|
4.
|
Aflibercept and Docetaxel versus Docetaxel alone after platinum failure in patients with advanced or metastatic non-small-cell lung cancer: a randomized, controlled phase III trial. [electronic resource] by
- Ramlau, Rodryg
- Gorbunova, Vera
- Ciuleanu, Tudor Eliade
- Novello, Silvia
- Ozguroglu, Mustafa
- Goksel, Tuncay
- Baldotto, Clarissa
- Bennouna, Jaafar
- Shepherd, Frances A
- Le-Guennec, Solenn
- Rey, Augustin
- Miller, Vincent
- Thatcher, Nicholas
- Scagliotti, Giorgio
Producer: 20121219
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 30
Availability: No items available.
|
|
5.
|
Ombrabulin plus cisplatin versus placebo plus cisplatin in patients with advanced soft-tissue sarcomas after failure of anthracycline and ifosfamide chemotherapy: a randomised, double-blind, placebo-controlled, phase 3 trial. [electronic resource] by
- Blay, Jean-Yves
- Pápai, Zsuzsanna
- Tolcher, Anthony W
- Italiano, Antoine
- Cupissol, Didier
- López-Pousa, Antonio
- Chawla, Sant P
- Bompas, Emmanuelle
- Babovic, Nada
- Penel, Nicolas
- Isambert, Nicolas
- Staddon, Arthur P
- Saâda-Bouzid, Esma
- Santoro, Armando
- Franke, Fabio A
- Cohen, Patrick
- Le-Guennec, Solenn
- Demetri, George D
Producer: 20150714
In:
The Lancet. Oncology vol. 16
Availability: No items available.
|
|
6.
|
Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study. [electronic resource] by
- Attal, Michel
- Richardson, Paul G
- Rajkumar, S Vincent
- San-Miguel, Jesus
- Beksac, Meral
- Spicka, Ivan
- Leleu, Xavier
- Schjesvold, Fredrik
- Moreau, Philippe
- Dimopoulos, Meletios A
- Huang, Jeffrey Shang-Yi
- Minarik, Jiri
- Cavo, Michele
- Prince, H Miles
- Macé, Sandrine
- Corzo, Kathryn P
- Campana, Frank
- Le-Guennec, Solenn
- Dubin, Franck
- Anderson, Kenneth C
Producer: 20200106
In:
Lancet (London, England) vol. 394
Availability: No items available.
|
|
7.
|
Aflibercept Plus FOLFIRI vs. Placebo Plus FOLFIRI in Second-Line Metastatic Colorectal Cancer: a Post Hoc Analysis of Survival from the Phase III VELOUR Study Subsequent to Exclusion of Patients who had Recurrence During or Within 6 Months of Completing Adjuvant Oxaliplatin-Based Therapy. [electronic resource] by
- Van Cutsem, Eric
- Joulain, Florence
- Hoff, Paulo M
- Mitchell, Edith
- Ruff, Paul
- Lakomý, Radek
- Prausová, Jana
- Moiseyenko, Vladimir M
- van Hazel, Guy
- Cunningham, David
- Arnold, Dirk
- Schmoll, Hans-Joachim
- Ten Tije, Albert J
- McKendrick, Joseph
- Kröning, Hendrik
- Humblet, Yves
- Grávalos, Cristina
- Le-Guennec, Solenn
- Andria, Michael
- Dochy, Emmanuelle
- Vishwanath, Raghu L
- Macarulla, Teresa
- Tabernero, Josep
Producer: 20171030
In:
Targeted oncology vol. 11
Availability: No items available.
|